Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Data Survey Report 2025

  • HEY2203703
  • 78 Pages
  • October 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Summary

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.

The global Glucagon Like Peptide-1 (GLP-1) Agonists market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Average market price by SUK

Major applications

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

Novo Nordisk

AstraZeneca

Eli Lily

GSK

Sanofi

Bristol-Myers Squibb

Amylin

Major applications as follows:

Hospital

Pharmacy

Others

Regional market size, production data and export & import:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Global Market Overview

1.1 Scope of Statistics

1.1.1 Scope of Products

1.1.2 Scope of Manufacturers

1.1.3 Scope of Application

1.1.4 Scope of Regions/Countries

1.2 Global Market Size

2 Regional Market

2.1 Regional Production

2.2 Regional Demand

2.3 Regional Trade

3 Key Manufacturers

3.1 Novo Nordisk

3.1.2 Company Information

3.1.2 Product Specifications

3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.2 AstraZeneca

3.2.1 Company Information

3.2.2 Product Specifications

3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.3 Eli Lily

3.3.1 Company Information

3.3.2 Product Specifications

3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.4 GSK

3.4.1 Company Information

3.4.2 Product Specifications

3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.5 Sanofi

3.5.1 Company Information

3.5.2 Product Specifications

3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.6 Bristol-Myers Squibb

3.6.1 Company Information

3.6.2 Product Specifications

3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.7 Amylin

3.7.1 Company Information

3.7.2 Product Specifications

3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

4.1 Hospital

4.1.1 Overview

4.1.2 Hospital Market Size and Forecast

4.2 Pharmacy

4.2.1 Overview

4.2.2 Pharmacy Market Size and Forecast

4.3 Others

4.3.1 Overview

4.3.2 Others Market Size and Forecast

5 Market Price

5.1 Overview

5.2 Price by SUK

6 Conclusion


List Of Tables
Tab Regional Production 2011-2017 (Value)

Tab Regional Production 2011-2017 (Volume)

Tab Regional Demand and CAGR 2011-2017 (Value)

Tab Regional Demand and CAGR 2011-2017 (Volume)

Tab Regional Demand Forecast and CAGR 2018-2025 (Value)

Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)

Tab Regional Export 2011-2017 (Value)

Tab Regional Export 2011-2017 (Volume)

Tab Regional Import 2011-2017 (Value)

Tab Regional Import 2011-2017 (Volume)

Tab Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk

Tab Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca

Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lily

Tab Sales Revenue, Volume, Price, Cost and Margin of GSK

Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi

Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb

Tab Sales Revenue, Volume, Price, Cost and Margin of Amylin

Tab Market Price by Region

Tab Market Price by Manufacturers

Tab Market Price by Application

Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2011-2017 (Value)

Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2011-2017 (Volume)

Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Value)

Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Volume)

Fig Hospital Market Size and CAGR 2011-2017 (Value)

Fig Hospital Market Size and CAGR 2011-2017 (Volume)

Fig Hospital Market Forecast and CAGR 2018-2025 (Value)

Fig Hospital Market Forecast and CAGR 2018-2025 (Volume)

Fig Pharmacy Market Size and CAGR 2011-2017 (Value)

Fig Pharmacy Market Size and CAGR 2011-2017 (Volume)

Fig Pharmacy Market Forecast and CAGR 2018-2025 (Value)

Fig Pharmacy Market Forecast and CAGR 2018-2025 (Volume)

Fig Others Market Size and CAGR 2011-2017 (Value)

Fig Others Market Size and CAGR 2011-2017 (Volume)

Fig Others Market Forecast and CAGR 2018-2025 (Value)

Fig Others Market Forecast and CAGR 2018-2025 (Volume)

Fig Global Market Price 2011-2017

Fig Global Market Price 2018-2025

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390